Johnson & Johnson announced a $5.5 billion [1] settlement to resolve tens of thousands [2] of U.S. lawsuits alleging its talc-based products cause ovarian cancer.
The agreement marks an attempt to end a decade-long legal battle and avoid further bankruptcies of subsidiary companies. This resolution addresses long-standing claims that the company's baby powder contained asbestos or otherwise caused cancer in users.
The announcement occurred on Monday, July 27, 2024 [4]. The settlement is designed to tie up remaining lawsuits in U.S. federal courts [5]. According to reports, the company intends to use this payment to clear a massive backlog of litigation that has persisted for years.
Dietrich Knauth of Yahoo Finance said, "After years of litigation, about 70,000 court cases [3], and three bankruptcies, Johnson & Johnson has agreed to a $5.5 billion talc settlement."
The legal strategy follows several attempts by the company to use bankruptcy filings to manage the volume of claims. By proposing this multibillion-dollar sum, Johnson & Johnson seeks a definitive end to the ovarian cancer litigation. A company spokesperson said the estimated $5.5 billion [1] would resolve the claims associated with baby powder, and other talc products [6].
While some reports describe the amount as a proposal, other sources state the company has already agreed to the payment [7]. The settlement covers a vast range of plaintiffs who alleged that the talc products they used contributed to the development of ovarian cancer over several decades.
“Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits”
This settlement represents a strategic shift for Johnson & Johnson as it moves away from the 'Texas Two-Step' bankruptcy maneuver to resolve its liabilities. By allocating a fixed sum to settle tens of thousands of claims, the company is prioritizing financial certainty and corporate stability over the continued risk of unpredictable jury awards in individual trials.
